Clidinium Bromide
Spezifikationen
3485-62-9CAS-Nummer
222-471-3EG-Nummer
(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate bromideIUPAC-Name
C22H26BrNO3Chemische Formel
432.3 g/molMolekulargewicht
CLIDINIUM BROMIDE; 3485-62-9; Quarzan; Bromuro de clidinio; Bromure de clidinium; Clidinii bromidum; Ro 2-3773; 3-Hydroxy-1-methylquinuclidinium bromide benzilate; Quinuclidinol methylbromide, benzilate; DTXSID7022835; 91ZQW5JF1Z; 1-Methyl-3-(benziloyloxy)quinuclidinium bromide; 3-(Benziloyloxy)-1-methylquinuclidinium bromide; NSC-756686; 3-(2,2-Diphenyl-2-hydroxyethanoyloxy)-quinuclidinium bromide; Ro-23773; Ro-2-3773; CHEBI:3744; DTXCID702835; 1-Azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, bromide; 1-Azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-, bromide; clidinio bromuro; clidinium (cation); RefChem:56516; 222-471-3; Clidinium (bromide); MFCD00078996; (1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide; MLS000028560; 1-Azoniabicyclo[2.2.2]octane, 3-[(hydroxydiphenylacetyl)oxy]-1-methyl-,bromide; (+-)-3-Hydroxy-1-methylquinuclidinium bromide benzilate; 3-(2-Hydroxy-2,2-diphenylacetoxy)-1-methylquinuclidin-1-ium bromide; 3-{[hydroxy(diphenyl)acetyl]oxy}-1-methyl-1-azoniabicyclo[2.2.2]octane bromide; C22H26BrNO3; SMR000058806; Clidinii bromidum [INN-Latin]; Bromure de clidinium [INN-French]; Bromuro de clidinio [INN-Spanish]; SR-01000000078; EINECS 222-471-3; UNII-91ZQW5JF1Z; Prestwick_71; 1-Methyl-3-benzil-oxyloxy-quinuclidinium bromide; Quarzan (TN); Quinuclidinium, 3-hydroxy-1-methyl-, bromide, benzilate; Clidinium bromide [USAN:USP:INN:BAN]; Opera_ID_114; NCGC00016630-01; CAS-3485-62-9; SCHEMBL99017; SCHEMBL99018; MLS001148169; MLS002222158; Clidinium bromide (USP/INN); SPECTRUM1500192; REGID_for_CID_19004; CLIDINIUM BROMIDE [MI]; orb1225230; orb1310294; Clidinium (bromide) (Standard); CLIDINIUM BROMIDE [INN]; CHEMBL1200950; CLIDINIUM BROMIDE [USAN]; HMS502C20; HY-B1132R; CLIDINIUM BROMIDE [VANDF]; CLIDINIUM BROMIDE [MART.]; GKEGFOKQMZHVOW-UHFFFAOYSA-M; HMS1570F05; HMS1920O15; HMS2091E22; HMS2097F05; HMS2230L12; HMS3370H21; HMS3714F05; HMS3886O06; HMS5084P06; Pharmakon1600-01500192; CLIDINIUM BROMIDE [USP-RS]; CLIDINIUM BROMIDE [WHO-DD]; HY-B1132; Tox21_110535; CCG-38925; NSC756686; AKOS015895118; Tox21_110535_1; CLIDINIUM BROMIDE [ORANGE BOOK]; CS-4737; KS-1295; NSC 756686; 1-Azoniabicyclo(2.2.2)octane, 3-((hydroxydiphenylacetyl)oxy)-1-methyl-, bromide, (+-)-; CLIDINIUM BROMIDE [USP IMPURITY]; CLIDINIUM BROMIDE [USP MONOGRAPH]; NCGC00018171-06; NCGC00094625-01; NCGC00094625-02; NCGC00094625-03; NCGC00094625-04; SMR000058806CLIDINIUM BROMIDE; AC-13157; DB-048690; NS00083708; ST51014934; D00716; D82064; SR-01000000078-2; SR-01000000078-4; Q27106183; 1-methylquinuclidin-3-yl 2-hydroxy-2,2-diphenylacetate, bromide; 3-(2-Hydroxy-2,2-diphenylacetoxy)-1-methylquinuclidin-1-iumbromide; (1-methylquinuclidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate;bromide; (1-methyl-1-azoniabicy-clo[2.2.2]oct-8-yl) 2-hydroxy-2,2-diphenyl-acetate bro-mide; 3-{[Hydroxydi(phenyl)acetyl]oxy}-1-methyl-1-azabicyclo[2.2.2]octan-1-ium bromide; 1-Azoniabicyclo[2.2.2]octane, 3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-1-methyl-, bromide (1:1)Synonyme
